Molly Cole

Molly (Bucklin) Cole, PhD, serves as the Head of Business Development and R&D Strategy at Shinobi Therapeutics, previously holding the position of R&D Strategy Lead. Prior experience includes a role as a Research Associate at F-Prime Capital and an Innovation Fellow at Yale University, where Molly conducted research under Dr. Carrie Lucas as an Immunology PhD student. Earlier academic involvement includes working as an Undergraduate Research Assistant under Dr. Carl June at the University of Pennsylvania. Molly earned a PhD in Immunology from Yale University in 2022 and a BA in Cell/Cellular and Molecular Biology from the University of Pennsylvania in 2018.